GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment

Yamamichi, Gaku; Kato, Taigo; Arakawa, Noriaki; Ino, Yoko; Ujike, Takeshi; Nakano, Kosuke; Koh, Yoko; Motoyama, Yuichi; Outani, Hidetatsu; Myoba, Shohei; Ishizuya, Yu; Yamamoto, Yoshiyuki; Hatano, Koji; Kawashima, Atsunari; Fukuhara, Shinichiro; Uemura, Hiroji; Okada, Seiji; Morii, Eiichi; Nonomura, Norio; Uemura, Motohide

doi:https://doi.org/10.1186/s40364-024-00695-6

GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment

Yamamichi, Gaku; Kato, Taigo; Arakawa, Noriaki et al.

Biomarker Research, 2024, 12, 147

アクセス数:31件（2025-03-18 18:49 集計）

固定URL: https://hdl.handle.net/11094/98514

閲覧可能ファイル

ファイル	フォーマット	利用条件	サイズ	閲覧回数	利用開始日	説明	information
BiomarkRes_12_147	pdf	なし	3.96 MB	28	2024.11.28

Creative Commons : 表示

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

タイトル	GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment
著者	NRID 1000040882262 1000040882262 researchmap permalink urology-osaka-japan urology-osaka-japan 著者名 Yamamichi, Gaku
	NRID 1000070648021 1000070648021 researchmap permalink taigokato taigokato Scopus Author ID 55414697500 55414697500 著者名 Kato, Taigo
	NRID 1000060398394 1000060398394 著者名 Arakawa, Noriaki
	著者名 Ino, Yoko
	著者名 Ujike, Takeshi
	NRID 1000000804410 1000000804410 researchmap permalink uro.med.osaka-u uro.med.osaka-u 著者名 Nakano, Kosuke
	NRID 1000070824754 1000070824754 researchmap permalink uro-koh uro-koh 著者名 Koh, Yoko
	NRID 1000060948074 1000060948074 researchmap permalink y_motoyama y_motoyama Scopus Author ID 57208337832 57208337832 著者名 Motoyama, Yuichi
	NRID 1000060727965 1000060727965 researchmap permalink h-otani h-otani Scopus Author ID 6506224785 6506224785 著者名 Outani, Hidetatsu
	著者名 Myoba, Shohei
	NRID 1000000783854 1000000783854 researchmap permalink okiishi okiishi 著者名 Ishizuya, Yu
	NRID 1000090759557 1000090759557 researchmap permalink yoshi229 yoshi229 著者名 Yamamoto, Yoshiyuki
	NRID 1000060762234 1000060762234 researchmap permalink koji_hatano koji_hatano Scopus Author ID 14627167600 14627167600 著者名 Hatano, Koji
	NRID 1000050746568 1000050746568 researchmap permalink akawashima akawashima Scopus Author ID 9846139400 9846139400 著者名 Kawashima, Atsunari
	NRID 1000020609870 1000020609870 researchmap permalink sf55 sf55 Scopus Author ID 8635237400 8635237400 著者名 Fukuhara, Shinichiro
	NRID 1000050244439 1000050244439 著者名 Uemura, Hiroji
	NRID 1000030448435 1000030448435 ORCID 0000-0002-5107-8209 0000-0002-5107-8209 researchmap permalink okadaseiji okadaseiji Scopus Author ID 35079139100 35079139100 著者名 Okada, Seiji
	NRID 1000010283772 1000010283772 ORCID 0000-0001-8490-3650 0000-0001-8490-3650 researchmap permalink read0046454 read0046454 Scopus Author ID 7003914326 7003914326 著者名 Morii, Eiichi
	NRID 1000030263263 1000030263263 researchmap permalink read0185096 read0185096 Scopus Author ID 7005880662 7005880662 著者名 Nonomura, Norio
	NRID 1000040631015 1000040631015 researchmap permalink urourouro urourouro 著者名 Uemura, Motohide
キーワード等	Castration-resistant prostate cancer
	Bone metastasis
	GDF15
	Biomarker
内容	Yamamichi Gaku, Kato Taigo, Arakawa Noriaki, et al. GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment. Biomarker Research 12, 147 (2024); https://doi.org/10.1186/s40364-024-00695-6.
抄録	Background: Bone metastasis (BM) is a common and fatal condition in patients with castration-resistant prostate cancer (CRPC). However, there are no useful blood biomarkers for CRPC with BM, and the mechanism underlying BM is unclear. In this study, we investigated precise blood biomarkers for evaluating BM that can improve the prognosis of patients with CRPC. Methods: We comprehensively examined culture supernatants from four prostate cancer (PCa) cell lines using Orbitrap mass spectrometry to identify specific proteins secreted abundantly by PCa cells. The effects of this protein to PCa cells, osteoblasts, osteoclasts were examined, and BM mouse model. In addition, we measured the plasma concentration of this protein in CRPC patients for whom bone scan index (BSI) by bone scintigraphy was performed. Results: A total of 2,787 proteins were identified by secretome analysis. We focused on GDF15 propeptide (GDPP), which is secreted by osteoblasts, osteoclasts, and PCa cells. GDPP promoted the proliferation, invasion, and migration of PC3 and DU145 CRPC cells, and GDPP aggravated BM in a mouse model. Importantly, GDPP accelerated bone formation and absorption in the bone microenvironment by enhancing the proliferation of osteoblasts and osteoclasts by upregulating individual transcription factors such as RUNX2, OSX, ATF4, NFATc1, and DC-STAMP. In clinical settings, including a total of 416 patients, GDPP was more diagnostic of BM than prostate-specific antigen (PSA) (AUC = 0.92 and 0.78) and the seven other blood biomarkers (alkaline phosphatase, lactate dehydrogenase, bone alkaline phosphatase, tartrate-resistant acid phosphatase 5b, osteocalcin, procollagen I N-terminal propeptide and mature GDF15) in patients with CRPC. The changes in BSI over time with systemic treatment were correlated with that of GDPP (r = 0.63) but not with that of PSA (r = -0.16). Conclusions: GDPP augments the tumor microenvironment of BM and is a novel blood biomarker of BM in CRPC, which could lead to early treatment interventions in patients with CRPC.
出版者	Springer Science and Business Media LLC
収録物名	Biomarker Research
巻(号)	12
ページ	147
刊行年月	2024-11-25
言語	英語
ハンドルURL	https://hdl.handle.net/11094/98514
eISSN	20507771
関連情報 (isIdenticalTo)	DOI (出版社版) https://doi.org/10.1186/s40364-024-00695-6
アクセス権	open access
権利情報	This article is licensed under a Creative Commons Attribution 4.0 International License.
出版タイプ	Version of Record
カテゴリ	学術雑誌論文 Journal Article

論文詳細を表示

資源タイプ	学術雑誌論文
ローカル資源タイプ	学術雑誌論文
DCTERMS.bibliographicCitation	Biomarker Research. 2024, 12, p. 147
DC.title	GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment
DC.creator	Yamamichi, Gaku
	Kato, Taigo
	Arakawa, Noriaki
	Ino, Yoko
	Ujike, Takeshi
	Nakano, Kosuke
	Koh, Yoko
	Motoyama, Yuichi
	Outani, Hidetatsu
	Myoba, Shohei
	Ishizuya, Yu
	Yamamoto, Yoshiyuki
	Hatano, Koji
	Kawashima, Atsunari
	Fukuhara, Shinichiro
	Uemura, Hiroji
	Okada, Seiji
	Morii, Eiichi
	Nonomura, Norio
	Uemura, Motohide
DC.publisher	Springer Science and Business Media LLC
DC.language' scheme='DCTERMS.RFC1766	英語
DCTERMS.issued' scheme='DCTERMS.W3CDTF	2024-11-25
DC.identifier	https://doi.org/10.1186/s40364-024-00695-6
DC.subject	Castration-resistant prostate cancer
	Bone metastasis
	GDF15
	Biomarker
DC.description	Yamamichi Gaku, Kato Taigo, Arakawa Noriaki, et al. GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment. Biomarker Research 12, 147 (2024); https://doi.org/10.1186/s40364-024-00695-6.
DCTERMS.abstract	Background: Bone metastasis (BM) is a common and fatal condition in patients with castration-resistant prostate cancer (CRPC). However, there are no useful blood biomarkers for CRPC with BM, and the mechanism underlying BM is unclear. In this study, we investigated precise blood biomarkers for evaluating BM that can improve the prognosis of patients with CRPC. Methods: We comprehensively examined culture supernatants from four prostate cancer (PCa) cell lines using Orbitrap mass spectrometry to identify specific proteins secreted abundantly by PCa cells. The effects of this protein to PCa cells, osteoblasts, osteoclasts were examined, and BM mouse model. In addition, we measured the plasma concentration of this protein in CRPC patients for whom bone scan index (BSI) by bone scintigraphy was performed. Results: A total of 2,787 proteins were identified by secretome analysis. We focused on GDF15 propeptide (GDPP), which is secreted by osteoblasts, osteoclasts, and PCa cells. GDPP promoted the proliferation, invasion, and migration of PC3 and DU145 CRPC cells, and GDPP aggravated BM in a mouse model. Importantly, GDPP accelerated bone formation and absorption in the bone microenvironment by enhancing the proliferation of osteoblasts and osteoclasts by upregulating individual transcription factors such as RUNX2, OSX, ATF4, NFATc1, and DC-STAMP. In clinical settings, including a total of 416 patients, GDPP was more diagnostic of BM than prostate-specific antigen (PSA) (AUC = 0.92 and 0.78) and the seven other blood biomarkers (alkaline phosphatase, lactate dehydrogenase, bone alkaline phosphatase, tartrate-resistant acid phosphatase 5b, osteocalcin, procollagen I N-terminal propeptide and mature GDF15) in patients with CRPC. The changes in BSI over time with systemic treatment were correlated with that of GDPP (r = 0.63) but not with that of PSA (r = -0.16). Conclusions: GDPP augments the tumor microenvironment of BM and is a novel blood biomarker of BM in CRPC, which could lead to early treatment interventions in patients with CRPC.
DC.rights	This article is licensed under a Creative Commons Attribution 4.0 International License.
DC.format	98514
citation_title	GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment
citation_author	Yamamichi, Gaku
	Kato, Taigo
	Arakawa, Noriaki
	Ino, Yoko
	Ujike, Takeshi
	Nakano, Kosuke
	Koh, Yoko
	Motoyama, Yuichi
	Outani, Hidetatsu
	Myoba, Shohei
	Ishizuya, Yu
	Yamamoto, Yoshiyuki
	Hatano, Koji
	Kawashima, Atsunari
	Fukuhara, Shinichiro
	Uemura, Hiroji
	Okada, Seiji
	Morii, Eiichi
	Nonomura, Norio
	Uemura, Motohide
citation_publisher	Springer Science and Business Media LLC
citation_language	英語
citation_date	2024-11-25
citation_journal_title	Biomarker Research
citation_volume	12
citation_firstpage	147
citation_doi	https://doi.org/10.1186/s40364-024-00695-6
citation_public_url	https://hdl.handle.net/11094/98514